UPDATE: Tabula Rasa HealthCare Q2 Adj EPS $0.03 Beats $(0.14) Estimate, Sales $90.04M Beat $88.82M Estimate
Portfolio Pulse from Happy Mohamed
Tabula Rasa HealthCare (NASDAQ:TRHC) reported Q2 earnings of $0.03 per share, beating the analyst consensus estimate of $(0.14) by 121.43%. This is a 105.66% increase from the same period last year. The company also reported quarterly sales of $90.04 million, beating the analyst consensus estimate of $88.82 million by 1.37%, a 24.02% increase from the same period last year.
August 07, 2023 | 12:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Tabula Rasa HealthCare reported Q2 earnings and sales that beat estimates. This could lead to a positive short-term impact on the company's stock.
Tabula Rasa HealthCare reported better than expected Q2 earnings and sales. This positive financial performance could increase investor confidence and demand for the stock, potentially leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100